DexCom stock falls over 38% as revenue forecast declines
DexCom has released its second quarter (Q2) financials reporting a 15% growth in revenue to $1bn, up from $871.3m in…
DexCom has released its second quarter (Q2) financials reporting a 15% growth in revenue to $1bn, up from $871.3m in…
US-based Know Labs has reported positive data from a proof-of-concept trial evaluating its device that non-invasively identifies the level of…
Medical technology innovator Roche has announced that its AI-enabled continuous glucose monitoring (CGM) solution has received the Conformité Européene mark,…
Roche, a biotechnology company with a focus on diagnostics, has announced that its AI-enabled continuous glucose monitoring system has gained…
Tandem Diabetes Care has shared positive new data from a user satisfaction and wearability survey, finding that 86% of participants…
Finnish tech-maker GlucoModicum will be upping manufacturing efforts of its Talisman CGM device following strong clinical data. The device combines…
The French Government are to offer national reimbursement for Dexcom’s ONE continuous glucose monitor (CGM) to patients treating their type…
Biosensor company Allez Health has raised $60m in Series A+ financing to advance its continuous glucose monitoring (CGM) technology. The…
Click Therapeutics, a medical technology company, has announced the acquisition of assets from Better Therapeutics, aiming to enhance its development…
Irish diagnostics and diabetes management company Trinity Biotech has partnered with an Irish medical artificial intelligence (AI) company PulseAI to…